Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Oxycodone
Drug ID BADD_D01645
Description Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917.[A178696] It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label] The first oxycodone containing product, Percodan, was approved by the FDA on April 12, 1950.[L6460]
Indications and Usage Oxycodone is indicated for the treatment of moderate to severe pain.[Label] There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.[Label]
Marketing Status approved; illicit; investigational
ATC Code N02AA05
DrugBank ID DB00497
KEGG ID D05312
MeSH ID D010098
PubChem ID 5284603
TTD Drug ID D07WPQ
NDC Product Code 71335-0981; 67651-0304; 67651-0305; 67651-0306; 24510-140; 71335-1080; 0904-6966; 24510-130; 65162-048; 67877-625; 71335-0677; 65162-050; 0904-7180; 65162-047; 72162-1812; 67877-623; 67651-0302; 65162-049; 67651-0303; 65162-051; 24510-110; 24510-115; 71335-1023; 24510-120; 72162-1811
UNII CD35PMG570
Synonyms Oxycodone | Dihydrone | Oxycone | Dihydrohydroxycodeinone | Oxycodeinon | Eucodal | Theocodin | Oxycodone Hydrochloride | Oxycontin | Pancodine | Dinarkon | Oxiconum
Chemical Information
Molecular Formula C18H21NO4
CAS Registry Number 76-42-6
SMILES CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Respiratory acidosis22.02.02.004; 14.01.04.0020.000114%Not Available
Respiratory arrest22.02.01.0090.000725%Not Available
Respiratory depression22.02.01.010; 17.02.05.0470.000487%Not Available
Respiratory disorder22.02.07.002--Not Available
Respiratory failure22.02.06.002; 14.01.04.003--
Restlessness19.11.02.002; 17.02.05.021--
Retching07.01.07.002--Not Available
Rhinitis22.07.03.006; 11.01.13.004--
Rhinorrhoea22.12.03.021--
Sciatica17.10.03.001; 15.10.01.0010.000128%Not Available
Sedation17.02.04.005--Not Available
Seizure17.12.03.001--
Sepsis11.01.11.003--
Serotonin syndrome17.05.02.004; 15.05.04.016; 12.03.01.041--Not Available
Sexual dysfunction21.03.02.003; 19.08.05.002--Not Available
Shock24.06.02.002--Not Available
Sinusitis22.07.03.007; 11.01.13.005--
Skin discolouration23.03.03.005--Not Available
Skin disorder23.03.03.007--Not Available
Sleep apnoea syndrome22.02.01.013; 19.02.05.002; 17.15.05.001--
Sneezing22.12.03.024--
Social avoidant behaviour19.05.01.007--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Speech disorder17.02.08.003; 22.12.03.027; 19.19.02.002--Not Available
Stomatitis07.05.06.005--
Stupor17.02.04.007; 19.02.05.004--Not Available
Sudden infant death syndrome18.04.01.007; 08.04.01.0090.000021%Not Available
Suicidal ideation19.12.01.003--
Suicide attempt19.12.01.004--
Supraventricular tachycardia02.03.03.012--
The 10th Page    First    Pre   10 11 12 13 14    Next   Last    Total 16 Pages